June 7, 2021 Lab Top-10 Life Science Tools Liq. Handling & Robotics Product Launch

Bruker Launches CE-IVD Quantitative Coronavirus Mid-Plex PCR Assay with Mutation Detection for Routine Variant Differentiation

FluoroType® SARS-CoV-2 varID Q is a novel LiquidArray® mid-plex PCR panel Detection of selected SARS-CoV-2 mutations enables differentiation of major viral variants, or strains, without the costs and delays of selective NGS for variant epidemiology Quantification of viral load provides indication of infectivity and of stage of COVID infection Validated with nasopharyngeal swabs and oropharyngeal... Read more

June 2, 2021 Chemicals, Reagents & Kits Life Science Tools Product Launch

Agilent Announces New SureSelect Human All Exon V8

Design provides comprehensive content and flexible exome options SANTA CLARA, Calif., June 02, 2021  Agilent Technologies Inc. (NYSE: A) today announced the release of SureSelect Human All Exon V8 – a new exome design that provides comprehensive content and up-to-date coverage of protein-coding regions from RefSeq, CCDS, and GENCODE. It also covers the TERT promoter and hard-to-capture... Read more

June 1, 2021 Lab Top-10 Mass Spectrometry Product Launch

Bruker Launches timsTOF SCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth

Unique timsTOF SCP revolutionizes quantitative single cell biology research with unbiased, deep single-cell 4D-Proteomics™ to complement scRNA-seq; breakthrough paper by Mann et al. identifies and quantifies >1,400 proteins in single cells Next-generation timsTOF Pro 2 with unprecedented depth and throughput for unbiased 4D-Proteomics; supports liquid biopsy multiomic biomarker research, integrating genomics with proteomics and epiproteomics;... Read more

June 1, 2021 Lab Top-10 Mass Spectrometry Product Launch

Bruker Launches timsTOF trueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth

Unique timsTOF trueSCP revolutionizes quantitative single cell biology research with unbiased, deep single-cell 4D-Proteomics™ to complement scRNA-seq; breakthrough paper by Mann et al. identifies and quantifies >1,400 proteins in single cells Next-generation timsTOF Pro 2 with unprecedented depth and throughput for unbiased 4D-Proteomics; supports liquid biopsy multiomic biomarker research, integrating genomics with proteomics and epiproteomics;... Read more

May 25, 2021 PAI Top-10 Product Launch

European Commission approves Venclyxto-based combinations for adults with newly diagnosed acute myeloid leukaemia who are ineligible for intensive chemotherapy

With hypomethylating agents significantly improved complete response rates in certain adults with newly diagnosed acute myeloid leukaemia In the VIALE-A study, Venclyxto plus azacitidine significantly improved overall survival in patients ineligible for intensive chemotherapy, a patient population who typically have a five-year overall survival rate of less than 10%1 Study data reinforces the potential of... Read more

May 21, 2021 PR/Corporate Product Launch

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 240,000 shares of... Read more

May 20, 2021 Atomic Spectroscopy Environ, Ag./Food & Bev Lab Top-10 Product Launch

Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities

Australian National Phenome Centre Integrates Quantitative NMR and MS Assay Platform for Risk Assessment and Longitudinal Monitoring of Post-Acute COVID-19 Syndrome (PACS) PERTH, Australia–(BUSINESS WIRE)– A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute... Read more

May 13, 2021 Lab Top-10 Product Launch

Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board also Declares Quarterly Dividend

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that on May 12, 2021, its Board of Directors approved a new share repurchase authorization for the purchase of up to $500 million of the Company’s common stock over a two-year period commencing on May 13, 2021. The share repurchase authorization permits shares to be repurchased... Read more